Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-12-23
2010-11-16
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S089000
Reexamination Certificate
active
07834010
ABSTRACT:
The invention relates to modulators of peripheral 5-HT receptors, particularly 5-HT4 receptors, said modulators essentially selective for peripheral 5-HT receptors over receptors of the central nervous system. The invention allows for the treatment, amongst others, of gastrointestinal disorders, lower urinary tract disorders, and cardiovascular disorders without side effects related to CNS activity.
REFERENCES:
patent: 4494547 (1985-01-01), Myers
patent: 6552004 (2003-04-01), Elazhary et al.
patent: 6552046 (2003-04-01), Druzgala et al.
patent: 6624163 (2003-09-01), Flohr et al.
patent: 6632827 (2003-10-01), McCullough et al.
patent: 2001/0031751 (2001-10-01), Bush et al.
patent: 2003/0019386 (2003-01-01), Lloyd et al.
patent: 1 149 832 (2001-10-01), None
patent: 11-292846 (1999-10-01), None
patent: WO 93/18036 (1993-09-01), None
patent: WO 96/10027 (1996-04-01), None
patent: WO 01/93849 (2001-12-01), None
International Search Report for International Application No. PCT/NO2004/000399 dated Aug. 17, 2005.
Muller-Lissner, et al. “Tegaserod, a 5-HT4receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.” Aliment Pharmacol Ther. 15:1655-1666 (2001).
Mutschler, et al. “Arzneimittelwirkungen.” WYG, Stuttgart. 462-466 (2001).
Sanger, et al. “SB-207266: 5-HT4receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitization of peristalsis and increased defaecation in animal models.” Neurogastroenterol. Mot. 10:271-279 (1998).
Awapara, Jorge. “2-Aminoethanesulfinic Acid: An Intermediate in the Oxidation of Cysteine in vivo.” Journal of Biological Chemistry. 183-188 (1952).
Weller et al. “The Detection of 3-Indoleacetic Acid in Cauliflower Heads. Chromatographic Behavior of Some Indole Compounds.” 76: 629-630 (1954).
Karl-Heinz et al. “The Serotonin 5-Ht4Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists.” J. Med. Chem. 38:2331-2338 (1995).
Kato, Hideo et al. “Preparation of benzamidopiperidinocarboxylates and pharmaceuticals for treatment of digestive system disease.” Abstract. Jan. 31, 2001.
Brudeli Bjarne
Klaveness Jo
Levy Finn Olav
Knobbe Martens Olson & Bear LLP
Serodus AS
Solola Taofiq A
LandOfFree
Modulators of peripheral 5-HT receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of peripheral 5-HT receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of peripheral 5-HT receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206504